Ameriprise’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.43M Buy
618,027
+165,481
+37% +$1.95M ﹤0.01% 2248
2026
Q2
$4.85M Buy
452,546
+346,659
+327% +$2.68M ﹤0.01% 2565
2026
Q1
$675K Buy
105,887
+2,595
+3% +$18.1K ﹤0.01% 3462
2025
Q4
$727K Sell
103,292
-40,946
-28% -$247K ﹤0.01% 3480
2025
Q3
$793K Buy
144,238
+66,074
+85% +$324K ﹤0.01% 3461
2025
Q2
$404K Buy
78,164
+58,721
+302% +$352K ﹤0.01% 3599
2025
Q1
$129K Buy
19,443
+7,645
+65% +$58.1K ﹤0.01% 3845
2024
Q4
$87K Buy
+11,798
New +$84.7K ﹤0.01% 3964
2021
Q3
– Sell
-18,776
Closed -$525K – 3905
2021
Q2
$525K Buy
+18,776
New +$496K ﹤0.01% 3444

Other funds holding LFST

Ameriprise's LFST Position: Q3 2026 in Review

Ameriprise increased its Lifestance Health (LFST) stake by 37% in Q3 2026, buying an estimated $1.95M and bringing the position to 618,027 shares worth $7.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Ameriprise first reported a position in LFST in Q2 2021 and has held it in 9 quarters since. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Ameriprise held 618,027 shares of Lifestance Health worth $7.43M as of Q3 2026.
  • Ameriprise bought 165,481 Lifestance Health shares in Q3 2026, an estimated $1.95M.
  • Lifestance Health made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2248 holding.
  • Ameriprise first reported a position in Lifestance Health in Q2 2021 and has held it in 9 quarters since.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.